Study Title | ZERO2: Precision Medicine for Every Child With Cancer |
---|---|
Protocol ID | ZERO2 |
Disease (Sub Disease) | All paediatric cancer types |
Diagnosis Stage | Newly diagnosed Relapsed/Refractory |
Location | NSW / QLD / VIC / WA / SA / NZ / TAS |
Sponsor | Australian & New Zealand Children's Haematology/Oncology Group |
Collaborators | Sydney Children's Hospitals Network |
Links | https://clinicaltrials.gov/ct2/show/NCT05504772 |
Trial Status | Open |
Trial Open Date | 16/12/2022 |
Sites | The Children's Hospital at Westmead / Sydney Children's Hospital / Queensland Children's Hospital / Women's & Children's Hospital / John Hunter Children's Hospital/ Royal Hobart Hospital/ Monash Children's Hospital/ The Royal Children's Hospital/ Perth Children's Hospital/ Starship Children's Hospital/ Christchurch Children's Hospital |
Study Type | Observational |
Phase | Not applicable |
Age Eligibility | 0 Years to 25 Years |
International registry ID's | NCT05504772 |